Recruiting

Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect

The purpose of this study is to test the feasibility and acceptability of an evidence-based treatment for depression delivered over an ipad, computer, or smartphone can help Adult Protective Services (APS) clients with their activities of daily living to evaluate whether reductions on measures of depression and apathy (a) mediate reduced Elder Neglect/Self Neglect (EN/SN) behaviors; and (b) whether secondary posited mediating mechanisms are also active in impacting depression and apathy

ClinicalTrials.gov IDNCT06910267
PhaseNA
Enrollment50
SponsorThe University of Texas Health Science Center, Houston
Age65 Years
SexALL
I'm interested View official listing

Conditions studied

Depression in Old Age

About this study

The purpose of this study is to test the feasibility and acceptability of an evidence-based treatment for depression delivered over an ipad, computer, or smartphone can help Adult Protective Services (APS) clients with their activities of daily living to evaluate whether reductions on measures of depression and apathy (a) mediate reduced Elder Neglect/Self Neglect (EN/SN) behaviors; and (b) whether secondary posited mediating mechanisms are also active in impacting depression and apathy

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * APS Case in APS Region VI- Must have open case * PHQ 9 score- Must have score of nine (9) or more Exclusion Criteria: * Previous mental health diagnosis of bipolar disorder, psychotic disorders, and moderate to severe dementia * Assessment of Consent Proxy- Those who need assessment of consent proxy * Suicidal Intent (as indexed by PhQ-9 question 9)- Those scoring 2 or 3 * Current Alcohol and Drug Dependency- As evidenced by Cut down, Annoyed, Guilty, and Eye-opener (CAGE) score of 3 or more

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.